caregiver perspective on pediatric attention- deficit/hyperactivity disorder: medication satisfaction and symptom control.NEUROPSYCHIATRIC DISEASE AND TREATMENT

In conclusion, caregiver responses in this European sample suggest that current treatment could potentially be improved. The observed correlations with global  symptom control and other CAPPA assessments provide support for the inter- connectivity of the medication...

Factors associated with caregiver burden among pharmacotherapy-treated children/adolescents with ADHD in the caregiver Perspective on Pediatric ADHD survey in Europe. NEUROPSYCHIATRIC DISEASE AND TREATMENT.

Burdens related to work, social activity, family life, and parental worry/stress were experienced by the caregivers of children/adolescents with ADHD, despite using ADHD pharmacotherapy. Better understanding of clinical/treatment characteristics most associated with...

Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment. NEUROPSYCHIATRIC DISEASE AND TREATMENT

Although there are no published studies that address the sequential efficacy of ADHD medication as their primary objective, such studies as the present one can be informative. Subgroup analyses in this study highlight the importance of considering the medication...